Drug-coated balloons or drug-eluting stents: Determining an optimum strategy for the high bleeding risk patients

Corballis, Natasha H., Nyi, Tha H., Vassiliou, Vassilios S. and Eccleshall, Simon C. (2020) Drug-coated balloons or drug-eluting stents: Determining an optimum strategy for the high bleeding risk patients. Heart International, 14 (2). pp. 100-104. ISSN 2036-2579

[img]
Preview
PDF (Accepted_Manuscript) - Accepted Version
Download (453kB) | Preview

Abstract

The management of patients who require percutaneous coronary intervention and are at high risk of bleeding continues to be challenging; balancing thrombotic risk versus bleeding risk to determine the safest duration of dual antiplatelet therapy (DAPT). With recent efforts to determine the safety of 1 month of DAPT after implantation of a drug-eluting stent, drug-coated balloons (DCBs) have also been explored as both have been shown superior to bare-metal stents which have historically been used for patients with high bleeding risk. We sought to review the literature surrounding the safety profile and bleeding events with both DCBs and drug-eluting stents, and conclude that whilst both offer safety of cessation of DAPT after 1 month, DCBs offer lower major adverse cardiovascular events.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: LivePure Connector
Date Deposited: 22 Jan 2021 00:58
Last Modified: 03 Nov 2021 08:17
URI: https://ueaeprints.uea.ac.uk/id/eprint/78254
DOI: 10.17925/HI.2020.14.2.100

Actions (login required)

View Item View Item